Smart Asthma Monitoring Device Market Trends

  • Report ID: 3918
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Smart Asthma Monitoring Device Market Trends

Growth Drivers  

  • Growing Cases of Asthma and COPD Globally – The existence of asthma and COPD diseases are growing rapidly with the increasing geriatric population, growth in the allergic reaction in response to pollen, dust, and other allergens, is leading to the growth in the market. In the year 2020, approx. of 40.7% adults of 18 and above years were diagnosed with asthmatic problems.
  • Rise in Indoor Air Pollutants – As the indoor air gets polluted it leads to harmful respiratory health problems and other chronic health issues, asthma is one of the health problems caused by bad indoor air. Therefore, this raises the demand for smart asthma monitoring devices in the further times. In 2020, indoor air pollution was considered to be the cause of 3.2 million annual deaths, including approximately 237 000 deaths of children under the age of five.
  • Increasing Technological Advancement – Advancements in technology in the healthcare system have led to the emergence of digital devices that aware patients from possible asthma attacks. These instruments contain the capability to monitor adherence, accurately record the time at which patients take a dose and also it offers access to real-time data that needs to be transported to personal device. All these advancements are expected to propel the market growth in the predicted period.

Challenges

  • Lack of Awareness about the Benefits of Smart Inhalers and Nebulizers - Asthma prevalence is on the rise as a result of increased pollution levels around the world, which has prompted businesses to create high-tech, low-cost monitoring tools to support patients' active commitment to self-monitoring practices. The market for smart asthma monitoring devices is predicted to grow slowly due to a lack of awareness regarding the proper usage of smart inhalers and nebulizers.
  • High Cost of Smart Monitoring Devices
  • Lack of Knowledge about the Device

Smart Asthma Monitoring Device Market: Key Insights

Healthcare Expenditure per Capita, (USD), 2015-2018

According to the statistics by the World Health Organization, the global per capita healthcare expenditure amounted to USD 1,064.741 in the year 2017. The worldwide healthcare expenditure per person grew from USD 864.313 in 2008 to USD 1,110.841 in 2018, where the U.S. is the top country that amounted to healthcare expenditure of USD 10, 623.85 per capita in 2018. As of 2018, the domestic general government healthcare spending in the U.S. was USD 5355.79, which grew from USD 3515.82 in 2008. These are some of the factors responsible for market growth over the past few years. Moreover, as per the projections by the Centers for Medicare & Medicaid Services (CMS), the estimated average annual percent change related to National Health Expenditures (NHE) in the U.S. was 5.2% in 2020 as compared to 2019 (4.5%). Furthermore, the National Health Expenditures are projected to reach USD 6,192.5 Billion in 2028, where the per capita expenditure is estimated to touch USD 17,611 in the same year. These are notable indicators that are anticipated to create lucrative business opportunities in upcoming years.

Base Year

2024

Forecast Year

2025-2037

CAGR

24.6%

Base Year Market Size (2024)

USD 1.47 billion

Forecast Year Market Size (2037)

USD 25.65 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 3918
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of smart asthma monitoring device is assessed at USD 2.11 billion.

The smart asthma monitoring device market size was over USD 1.47 billion in 2024 and is projected to reach USD 25.65 billion by 2037, witnessing around 24.6% CAGR during the forecast period i.e., between 2025-2037. The growing prevalence of asthma, backed by rapid urbanization will drive the market growth.

North America industry is likely to hold largest revenue share of 38% by 2037, driven by high incidence of asthma in developed nations.

The major players in the market are Astellas Pharma Inc., Adherium Limited, AstraZeneca Group, Cohero Health, Inc., GlaxoSmithKline plc, Aevice Health, Vectura Group plc, BioTelemetry, Inc., Health Care Originals Inc., Reciprocal Labs Corporation
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample